Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.
Article Details
- CitationCopy to clipboard
Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT
Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.
Bioorg Med Chem Lett. 2003 Dec 15;13(24):4477-80.
- PubMed ID
- 14643350 [ View in PubMed]
- Abstract
A series of naphthalenyloxy-arylpropylamines have been prepared and are demonstrated to be inhibitors of both serotonin and norepinephrine reuptake. One member of this series, duloxetine (Cymbalta) has proven to be effective in clinical trials for the treatment of depression.
DrugBank Data that Cites this Article
- Binding Properties
Drug Target Property Measurement pH Temperature (°C) Duloxetine Sodium-dependent dopamine transporter Ki (nM) 240 N/A N/A Details Duloxetine Sodium-dependent noradrenaline transporter Ki (nM) 7.5 N/A N/A Details Duloxetine Sodium-dependent serotonin transporter Ki (nM) 0.8 N/A N/A Details